Skip to main content
Joseph Witztum, MD, Endocrinology, La Jolla, CA

JosephLWitztumMD

Endocrinology • La Jolla, CA

Diabetes, Lipid Metabolism

Professor, Medicine, UCSD School of Medicine

Join to view full profile

Dr. Witztum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Witztum's full profile

Already have an account?

  • Office

    9434 Medical Center Dr
    La Jolla, CA 92037
    Phone+1 619-543-6164
    Fax+1 619-543-3183

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1969 - 1971
  • Washington University in St. Louis School of Medicine
    Washington University in St. Louis School of MedicineClass of 1969

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1975 - 2026
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1984

Publications & Presentations

PubMed

Press Mentions

  • FDA-Rejected Tx for FCS Proves Mettle in Phase III Trial
    FDA-Rejected Tx for FCS Proves Mettle in Phase III TrialAugust 7th, 2019
  • Antibodies Against Oxidized Phospholipids Protect Against Osteoporosis
    Antibodies Against Oxidized Phospholipids Protect Against OsteoporosisOctober 18th, 2018
  • Antibody Blocks Inflammation, Protects Mice from Hardened Arteries and Liver Disease
    Antibody Blocks Inflammation, Protects Mice from Hardened Arteries and Liver DiseaseJune 7th, 2018
  • Join now to see all

Grant Support

  • Program Project: Role Of Innate Immunity In AtherosclerosisNational Heart, Lung, And Blood Institute2009–2012
  • Role Of Innate Immune Mechanisms In AtherogenesisNational Heart, Lung, And Blood Institute2008–2012
  • Administrative CoreNational Heart, Lung, And Blood Institute2008–2012
  • Bridge D: Oxidize Lipids In MacrophagesNational Institute Of General Medical Sciences2008–2011
  • Development Of A Vaccine Approach To Inhibit AtherosclerosisNational Heart, Lung, And Blood Institute2007–2011
  • Evaluation Of Patients With HyperlipidemiaNational Center For Research Resources1995–2010
  • Role Of Innate Immunity In AtherosclerosisNational Heart, Lung, And Blood Institute2008
  • Bridge D: Oxidized Lipids In MacrophagesNational Institute Of General Medical Sciences2003–2007
  • Core A-- ImmunologyNational Heart, Lung, And Blood Institute2004–2006
  • Immune Responses To Oxldl And AtherosclerosisNational Heart, Lung, And Blood Institute2002–2006
  • SCOR In Molecular Medicine And AtherosclerosisNational Heart, Lung, And Blood Institute1997–2006
  • Gene Transfer Of Recombinant Antibody ProteinsNational Heart, Lung, And Blood Institute2001–2005
  • Core D-- Administrative CoreNational Heart, Lung, And Blood Institute2004
  • Role Of B-1 Lymphocytes In AthergenesisNational Heart, Lung, And Blood Institute2002–2004
  • Anticardiolipin Antibodies And Oxidized PhospholipidsNational Heart, Lung, And Blood Institute1997–2004
  • Core--ImmunologyNational Heart, Lung, And Blood Institute1997–2003
  • Localization Of Antibodies To Oxidized LDL In Normal &Apoptotic CellsNational Center For Research Resources1998–2002
  • Role Of B-1 Lymphocytes In AtherogenesisNational Heart, Lung, And Blood Institute2001
  • B-Lymphocyte Mediated Immune Mechanisms In AtherogenesisNational Heart, Lung, And Blood Institute2000–2001
  • Relationship Of Immunolgical Response To Modified LDL And AtherosclerosisNational Heart, Lung, And Blood Institute1997–2001
  • Mk733 Zocor GEM StudyNational Center For Research Resources1998–1999
  • Core--ImmunologyNational Heart, Lung, And Blood Institute1996–1997
  • Consequences Of Postsecretory Modifications Of LipoproteinsNational Heart, Lung, And Blood Institute1996–1997
  • Clinical Studies Of Lipoprotein MetabolismNational Heart, Lung, And Blood Institute1996–1997
  • Apolipoprotein E Deficiency And AtherosclerosisNational Heart, Lung, And Blood Institute1990

Dr. Joseph Witztum, Dr. Joseph Witztum, MD, Dr. J Witztum, Dr. Joseph L Witztum